Close
Novotech
Jabsco PureFlo 21 Single Use

News

Scivita Medical Raises Nearly RMB0.4 Billion in Series A Funding Round and Strives to Build A World-leading Platform for Innovative Products in Endoscope and...

Scivita Medical Technology Co., Ltd. ("Scivita Medical") announced that it has raised nearly RMB0.4 Billion in Series A funding round, which has become one of the highest financing projects in the field of endoscope in China in recent years....

Dachser Shanghai is recognized as CEIV Pharma Certified by IATA

International Logistics service provider Dachser received the Center of Excellence for Independent Validators in Pharmaceutical Logistics (CEIV Pharma) certification from IATA for its Shanghai organization including its PVG airport branch in March 2021. This marks the finalization of a...

Novavax to Participate in University of Oxford Com-COV2 Study Comparing Mixed COVID-19 Vaccine Combinations

Novavax, Inc., a biotechnology company developing next-generation vaccines for serious infectious diseases, announced its participation in a newly expanded investigator-initiated Phase 2 clinical trial called Comparing COVID-19 Vaccine Schedule Combinations – Stage 2 (Com-COV2), to be conducted by the...

Malvern Panalytical and Concept Life Sciences announce integration

Malvern Panalytical, manufacturer of analytical systems, and Concept Life Sciences (Cheshire, UK), a contract research organization, have today announced a full business integration. The integration will expand the existing analytical instrument and service relationship (Amplify Analytics) to include the...

aTyr Pharma and Lonza Announce Manufacturing Agreement for aTyrs Anti-NRP2 Antibody ATYR2810

“As we prepare to advance ATYR2810 to clinical stage development, we are pleased to work with Lonza, a partner with extensive and proven capability in antibody manufacturing, for the production of our first anti-NRP2 antibody. Having recently initiated IND-enabling...

Moderna Provides Clinical and Supply Updates on COVID-19 Vaccine Program Ahead of 2nd Annual Vaccines Day

Moderna, Inc. a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced clinical and supply updates on its COVID-19 Vaccine program. New results from a preclinical study of the Company’s COVID-19 variant-specific vaccine candidates showed that the Company’s...

Abzena announces location of new biologics GMP manufacturing site with up to 12 X 2000L bioreactors

Abzena is a Global Partner Research Organization (PRO) specializing in the integrated development and manufacture of complex biologics and bioconjugates has announced that the location of its new GMP manufacturing facility will be Sanford, North Carolina. The significant expansion...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »